In Re RUDY

Court of Appeals for the Federal Circuit·Decided April 24, 2020·No. 19-2301·Published

Opinion

United States Court of Appeals for the Federal Circuit

IN RE: CHRISTOPHER JOHN RUDY, Appellant

2019-2301

Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. 07/425,360.

Decided: April 24, 2020

CHRISTOPHER JOHN RUDY, Port Huron, MI, pro se.

MAI-TRANG DUC DANG, Office of the Solicitor, United States Patent and Trademark Office, Alexandria, VA, for appellee Andrei Iancu. Also represented by THOMAS W. KRAUSE, DANIEL KAZHDAN.

Before PROST, Chief Judge, O’MALLEY and TARANTO, Circuit Judges.

PROST, Chief Judge.

Christopher Rudy appeals from a decision of the Patent Trial and Appeal Board (“Board”) affirming the rejection of claims 34, 35, 37, 38, 40, and 45–49 of United States Patent Application No. 07/425,360 (“the ’360 application”) as ineligible for patenting under 35 U.S.C. § 101. We affirm.

2 IN RE: RUDY

I

Mr. Rudy originally filed the ’360 application on October 21, 1989. The application, entitled “Eyeless, Knotless, Colorable and/or Translucent/Transparent Fishing Hooks with Associatable Apparatus and Methods,” has undergone a lengthy prosecution, including numerous amendments and petitions, four Board appeals, and a previous trip to this court in which we affirmed the obviousness of all claims then on appeal. In re Rudy, 558 F. App’x. 1011 (Fed. Cir. 2014).

Claims 34, 35, 37, 38, 40, and 45–49 of the ’360 application were the subject of a March 2015 office action in which the Examiner rejected them as ineligible for patenting under 35 U.S.C. § 101. That rejection was made final in September 2015, and affirmed by the Board on October 2, 2019. 1 Claim 34, which the Board considered illustrative , recites the following:

34. A method for fishing comprising steps of (1) observing clarity of water to be fished to determine whether the water is clear, stained, or muddy, (2) measuring light transmittance at a depth in the water where a fishing hook is to be placed, and then (3) selecting a colored or colorless quality of the fishing hook to be used by matching the observed water conditions ((1) and (2)) with a color or colorless quality which has been previously determined to be less attractive under said conditions than

1 Claims 26–33 and 54–60 stand allowed. All remaining claims of the ’360 application have been cancelled by the applicant. J.A. 957–58.

IN RE: RUDY 3

those pointed out by the following correlation for fish-attractive non-fluorescent colors:

J.A. 24, claim 34 (formatting adjusted).

The Board conducted its analysis under a dual framework for patent eligibility, purporting to apply both 1) “the two-step framework described in Mayo [Collaborative Services v. Prometheus Laboratories, Inc., 566 U.S. 66 (2012)] and Alice [Corp. v. CLS Bank International, 573 U.S. 208 (2014)],” and 2) the Patent and Trademark Office’s 2019 Revised Patent Subject Matter Eligibility Guidance, 84 Fed. Reg. 50 (Jan. 7, 2019) (“Office Guidance”). 2 J.A. 4–5.

2 Shortly after the Board issued its decision in this case, the Patent Office issued supplemental guidance. See October 2019 Patent Eligibility Guidance Update, 84 Fed. Reg. 55942 (Oct. 18, 2019). Although the supplement’s substantive eligibility analysis is not relevant to this appeal, 4 IN RE: RUDY

The Board concluded “[u]nder the first step of the Mayo/Alice framework and Step 2A, Prong 1, of [the] Office Guidelines” that claim 34 is directed to the abstract idea of “select[ing] a colored or colorless quality of a fishing hook based on observed and measured water conditions, which is a concept performed in the human mind.” J.A. 9. The Board went on to conclude that “[u]nder the second step in the Mayo/Alice framework, and Step 2B of the 2019 Revised Guidance, we determine that the claim limitations, taken individually or as an ordered combination, do not amount to significantly more than” the abstract idea. J.A. 11.

Mr. Rudy timely appealed, challenging both the Board’s reliance on the Office Guidance, and the Board’s ultimate conclusion that the claims are not patent eligible. We have jurisdiction under 28 U.S.C. § 1295(a)(4)(A).

II

Mr. Rudy contends that the Board “misapplied or refused to apply . . . case law” in its subject matter eligibility analysis and committed legal error by instead applying the Office Guidance “as if it were prevailing law.” Appellant’s Br. 1. Mr. Rudy argues that the Office Guidance “simplistically represent[s] patent-eligible subject matter law,” and is used by the Patent Office as a “shortcut to ease Mayo/Alice test application, with no force or effect of law.” Appellant ’s Arg. 3 3; Reply Br. 7–8. We agree with Mr. Rudy that the Office Guidance is not, itself, the law of patent eligibility , does not carry the force of law, and is not binding in our patent eligibility analysis.

our discussion of the role of the Office Guidance applies equally to the supplement.

3 Appellant’s Arg. refers to the Attached Argument Sheet submitted as an attachment to Mr. Rudy’s informal opening brief.

IN RE: RUDY 5

Section 101 of the Patent Act provides that “[w]hoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title.” 35 U.S.C. § 101. However, the Supreme Court “ha[s] long held that this provision contains an important implicit exception : Laws of nature, natural phenomena, and abstract ideas are not patentable.” Assoc. for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. 589 (2013) (quoting Mayo, 566 U.S. at 71).

In determining whether those judicial exceptions apply , we are bound to “follow the Supreme Court’s two-step framework for patent eligibility under § 101.” Customedia Techs., LLC v. Dish Network Corp., 951 F.3d 1359, 1362 (Fed. Cir. 2020) (citing Alice, 573 U.S. at 217); see also Rivers v. Roadway Express, Inc., 511 U.S. 298, 312 (1994) (“[O]nce the [Supreme] Court has spoken, it is the duty of other courts to respect that understanding of the governing rule of law.”) We are similarly bound by our own fulsome precedent on the proper application of the Supreme Court’s test. Newell Cos., Inc. v. Kenney Mfg. Co., 864 F.2d 757, 765 (Fed. Cir. 1988) (“This Court has adopted the rule that prior decisions of a panel of the court are binding precedent on subsequent panels unless and until overturned [e]n banc.”); see Customedia, 951 F.3d at 1362–66 (collecting cases).

We are not, however, bound by the Office Guidance, which cannot modify or supplant the Supreme Court’s law regarding patent eligibility, or our interpretation and application thereof. As we have previously explained:

While we greatly respect the PTO’s expertise on all matters relating to patentability, including patent eligibility, we are not bound by its guidance. And, especially regarding the issue of patent eligibility and the efforts of the courts to determine the 6 IN RE: RUDY

distinction between claims directed to [judicial exceptions ] and those directed to patent-eligible applications of those [exceptions], we are mindful of the need for consistent application of our case law.

Cleveland Clinic Found. v. True Health Diagnostics LLC, 760 F. App’x. 1013, 1020 (Fed. Cir. 2019) (non-precedential ). Accordingly, we apply our law and the relevant Supreme Court precedent, not the Office Guidance, when analyzing subject matter eligibility. To the extent the Office Guidance contradicts or does not fully accord with our caselaw, it is our caselaw, and the Supreme Court precedent it is based upon, that must control. See id. at 1021 (holding claims ineligible, despite Office Guidance suggesting otherwise, where statements and examples in the Guidance were inconsistent with Ariosa Diagnostics, Inc. v. Sequenom, Inc., 788 F.3d 1371 (Fed. Cir. 2015)).

III

Free access — add to your briefcase to read the full text and ask questions with AI

In Re RUDY, (Fed. Cir. 2020).

In Re RUDY (In Re RUDY) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Rivers v. Roadway Express, Inc.
511 U.S. 298 (Supreme Court, 1994)
Ariosa Diagnostics, Inc. v. Sequenom, Inc.
788 F.3d 1371 (Federal Circuit, 2015)
Redline Detection, LLC v. Star Envirotech, Inc.
811 F.3d 435 (Federal Circuit, 2015)
Electric Power Group, LLC v. Alstom S.A.
830 F.3d 1350 (Federal Circuit, 2016)
Affinity Labs of Texas, LLC v. Directv, LLC
838 F.3d 1253 (Federal Circuit, 2016)
Chargepoint, Inc. v. Semaconnect, Inc.
920 F.3d 759 (Federal Circuit, 2019)
Sanofi-Aventis U.S., LLC v. Fresenius Kabi USA, LLC
933 F.3d 1367 (Federal Circuit, 2019)
Bilski v. Kappos
177 L. Ed. 2d 792 (Supreme Court, 2010)
Sri Int'l, Inc. v. Cisco Sys., Inc.
930 F.3d 1295 (Federal Circuit, 2019)